Search PubMed⌕ Search

PubMed · 10067109

[Stent therapy].

Abstract

Expandable metal stents are a significant advance in the treatment of malignant gastrointestinal tract obstruction. The devices available are not perfect in design and need further technical improvement. However they already offer advantages over conventional plastic stents. They are becoming standard for esophageal stenting. Indications for metal stents in other locations of the gastrointestinal tract have to be evaluated. Endoscopic stenting is now the method of choice in the palliative treatment of jaundice in patients with inoperable biliopancreatic neoplasias. Stent clogging as a result of biliary sludge and biofilm remains an unsolved problem of plastic stents. Expandable metal stents remain patent longer but are reserved for patients with good general health.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H Schwacha. 1999-01-14. [Stent therapy].. https://pubmed.ncbi.nlm.nih.gov/10067109/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Consensus on the management of obstetric cholestasis: National UK survey.

An anonymous questionnaire was sent to the lead consultant obstetricians and the midwives in charge of the antenatal clinics of all maternity units in UK to determine their current views on the diagnosis and management of obstetric cholestasis (OC). The response rate was 60%. Management policies were broadly similar and consistent with those recommended in the current literature. However, the survey highlighted areas for improvement. Based on the findings of this survey, a consensus view of the management of OC in UK is achievable.

Cholestasis↗

[Cholestasis in adults. 2. Clinical signs and symptomatic treatment].

Cholestasis, a frequent occurrence in clinical practice, can be suspected when confronted to clinical signs (pruritus and jaundice) and/or increased blood level of alkaline phosphatases, gammaglutamyl transpeptidase and/or conjugated bilirubin. This short review will deal with the management of clinical manifestations and extrahepatic complications, whatever the cause of cholestasis. The management according to etiology will be dealt with in a separated chapter.

Cholestasis↗